Conditions on veterinary medicines

In addition to the potential to cause residues, the use of veterinary medicines in a manner that has not been assessed by MAF may result in unnecessary pain or distress in the animal(s) treated. It cannot be assumed that a product that is safe to use in one kind of animal will be safe to use in any other kind of animal.

After consultation with interested and affected parties, MAF considers that it is not adequately protecting the welfare of animals to simply place a responsibility on the user to mitigate any pain or distress caused (see ACVM Animal Welfare Concerns, page 6). Therefore, alternative uses may be approved if the animal safety data confirm that the product will not cause unnecessary pain or distress.

The uses recommended by the registrant will be specified in registration condition 1 below.

1. The product has been assessed in regard to residues and animal safety for use on or in specified types of animals as recommended by the registrant. It may be used*:
   1. on/around any of the following types of animals:
      • (specified animals);

      and

   2. in the following manner:
      • frequency and dose rate;
      • means of administration as specified;
      • withholding period from last administration to harvesting of specified animal material.

   *Where necessary and appropriate there will be a qualifier that specifically prohibits the use of the product on a particular type of animals, or under particular circumstances.

   There are no assurances or warranties from MAF as to the effectiveness of the product when used as recommended by the registrant.

   Registration conditions 2 and 3 below will legalise uses not recommended by the registrant.

2. Apart from any prohibition listed in 1 above, this product may be used in or on any type of animal for any purpose by a veterinarian registered under the Veterinarians Act 1994, when acting in accordance with any applicable code of practice approved under section 28 of the ACVM Act and on animals under the direct care (direct care or prescription) of that veterinarian.
   
   
3. The product has been assessed for use on or in specified types of animals. It may be used:
   1. on or in any of the following types of animals:
      • (specified types of animals);

      and

   2. in the following manner;
      • frequency and dose rate;
      • means of administration as specified;
      • withholding period from last administration to harvesting of specified animal material.

Uses in 2 and 3 are not recommended by the registrant. There are no assurances or warranties from either MAF or the registrant as to the effectiveness or appropriateness of the product. Use at your own risk.